Processa Pharmaceuticals, Inc.
Annual report (10-K)
Latest 10-K/A filed Apr 30, 2026. Sentiment + YoY language diff vs prior year. Read sections →
Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.
Recent 8-K announcements
Per-item disclosure feed. Item 2.02 is the earnings release.
Top insiders
Most active reporters at Processa Pharmaceuticals, Inc.
| Name | Roles | Filings |
|---|---|---|
| Floyd Robert Michael | Officer | 7 |
| Neal James R | Director | 6 |
| Thompson Virgil | Director | 4 |
| Islam Khalid | Director | 2 |
Showing 11-14 of 14
Top performers
Insiders ranked by realized 90-day signed return on their open-market trades at Processa Pharmaceuticals, Inc.. Minimum 3 scored trades. Returns are signed - a sale followed by a rally counts against the insider.
| # | Insider | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|---|
| 1 | Yorke Justin W | 3 | 33% | -21.5% | -22.2% | +19.3% | -61.6% |
| 2 | Young David | 8 | 50% | -11.1% | +1.5% | +15.0% | -61.6% |
| 3 | Lin Patrick | 7 | 14% | -4.5% | -7.9% | +72.5% | -61.6% |
All filings
180 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|